🇺🇸 FDA
Patent

US 8993585

Cyclic amine substituted pyrimidinediamines as PKC inhibitors

granted A61PA61P1/04A61P1/18

Quick answer

US patent 8993585 (Cyclic amine substituted pyrimidinediamines as PKC inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P1/04, A61P1/18, A61P11/00, A61P11/02